Rephonic
Artwork for Lung Cancer Update

Lung Cancer Update

Dr. Neil Love
Non-Small Cell Lung Cancer
Immunotherapy
Lung Cancer
Small Cell Lung Cancer
Chemotherapy
Pembrolizumab
Egfr
Targeted Therapy
Clinical Trials
Osimertinib
EGFR Mutations
Antibody Drug Conjugates
Antibody-Drug Conjugates
Adjuvant Therapy
Neoadjuvant Chemotherapy
EGFR Mutation
Alk-Targeted Therapy
Adora Trial
Nivolumab
Pd-L1 Expression

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

PublishesTwice weeklyEpisodes359Founded20 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Lung Cancer Update

Latest Episodes

Featuring perspectives from Prof Solange Peters and Dr Joshua K Sabari, including the following topics:

• Introduction (0:00)

• Best Option for Your Patient (1:28)

• Biological Considerations (6:26)

• KRAS G12C Inhibitors (11:33)

• Second-Line Treat... more

Featuring an interview with Prof Ticiana Leal, including the following topics:

• Pathophysiology and clinical signs and symptoms (0:00)

• Screening and/or diagnostic approaches (5:45)

• Potential impact of available therapies for small cell lung can... more

Featuring perspectives from Dr Anne Chiang, Dr Apar Kishor Ganti, Dr Luis Paz-Ares and Dr Misty Dawn Shields, moderated by Dr Shields, including the following topics:

• Introduction (0:00)

• Optimizing First-Line and Maintenance Therapy for Extensiv... more

YouTube

Featuring perspectives from Dr John V Heymach and Dr Maurice Pérol, including the following topics:

• Introduction: Relative Impact of Targeted Treatment (00:00)

• HER2 Alterations (8:04)

• KRAS Mutations (24:25)

• MET Overexpression (30:34)

• ALK F... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Solange Peters
Professor, Lausanne University Hospital
Lausanne University Hospital
Episode: Non-Small Cell Lung Cancer — Targeting KRAS G12C
Josh Sabari
Physician-scientist, Perlmutter Cancer Center / NYU Langone
Perlmutter Cancer Center, NYU Grossman School of Medicine
Episode: Non-Small Cell Lung Cancer — Targeting KRAS G12C
Ticiana Leal
Professor at Winship Cancer Institute, Emory University
Winship Cancer Institute, Emory University
Episode: Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal
Charu Agarwal
Oncologist from University of Pennsylvania
University of Pennsylvania
Episode: Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Tisiana Leal
Oncologist from Emory University
Emory University
Episode: Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
John Heymach
Oncologist from University of Texas, MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR
Maurice Pérol
Professor at Léon-Bérard Center
Léon-Bérard Center
Episode: Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR
Dr. Joshua Sabari
Discussion with NYU Langone Health Perlmutter Cancer Center
New York University Langone Health, Perlmutter Cancer Center
Episode: HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 2
Dr. Antonio Passaro
Lecturer presenting first-line blocks and data on EGFR-mutant NSCLC
Division of Thoracic Oncology, European Institute of Oncology
Episode: EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Host

Dr. Neil Love
Host of the podcast series; conducts one-on-one interviews and moderates discussions across thoracic oncology topics

Reviews

4.5 out of 5 stars from 48 ratings
  • Medicine resident subscriber

    Third year medicine resident applying to Heme onc fellowship. I am interested in lung cancer and this podcast inspires critical thinking about patient management and provokes thought about the lung cancer literature. Uniquely has fantastic interviews with experts in the field. A great listen. I recommend this to anyone interested in oncology and interested in improving their knowledge of lung cancer management.

    Apple Podcasts
    5
    MG2MD
    United States8 years ago
  • Heldere informatie over longkanker

    Hier ben ik heel blij mee.

    Ik wou dat zoiets in het Nederlands bestond.

    Apple Podcasts
    5
    Thea 1953
    Netherlands15 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Fans appreciate the breadth of topics from targeted therapies to CNS considerations and liquid biopsy.
Listeners praise in-depth expert interviews and practical guidance for real-world lung cancer management.
Audiences value case-based discussions and data interpretation that help translate trials into patient care.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#171
Norway/Science
Apple Podcasts
#186
Israel/Science

Talking Points

Recent interactions between the hosts and their guests.

Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal
Q: What have you learned from case studies about using immunotherapy in patients with LEMS, particularly regarding safety and outcomes?
Data are limited, but some patients with LEMS may benefit from cancer immunotherapy without necessarily experiencing worsening neurologic symptoms; decisions must balance potential cancer control with the risk of immune-related adverse events, and multidisciplinary input is essential.
Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal
Q: Could you summarize the role of amifampridine and how you implement its dosing and monitoring in practice?
Amifampridine is used as a symptomatic therapy to improve muscle strength; it is started at low doses (5 mg divided into three doses) with gradual weekly titration up to about 80 mg daily, monitoring for tingling paresthesias and other side effects, and it's often continued alongside cancer treatment for functional improvement.
Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal
Q: What are the key clinical features that help distinguish LEMS from myasthenia gravis, and how does this influence management?
LEMS typically presents with proximal weakness, autonomic symptoms, and hyporeflexia, with less ocular involvement early on, unlike myasthenia gravis which often presents with ptosis, diplopia, and bulbar symptoms; distinguishing these guides therapy choices, including the consideration of agents like amifampridine for LEMS.
Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal
Q: So, can you talk a little bit more about your understanding of the pathophysiology, like what the antibody actually is attacking and how that leads to clinical outcomes?
LEMS involves autoantibodies against presynaptic voltage-gated calcium channels, which impairs calcium influx and acetylcholine release at the neuromuscular junction, resulting in proximal muscle weakness and the characteristic dysautonomic features, particularly in the setting of small cell lung cancer.
HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review
Q: What do we know about sequencing HER2-targeted therapies if a patient progresses on one agent—can they still respond to another later on?
There is limited head-to-head data, but real-world and cross-trial observations suggest activity can persist with different mechanisms of action; for example, responses to Trastuzumab Deroxetecan after TKIs and vice versa may occur, underscoring the importance of sequencing based on mechanism and prior responses.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Lung Cancer Update

What is Lung Cancer Update about and what kind of topics does it cover?

Clinician-to-clinician conversations feature leading medical oncologists and thoracic oncology experts discussing the latest data, trial results, and real-world management of lung cancer across subtypes. Episodes cover targeted therapies (EGFR, HER2, ROS1, RET), small cell lung cancer, CNS involvement, liquid biopsy and ctDNA, immunotherapy strategies, and antibody-drug conjugates, with practical case discussions and sequencing decisions. The show often emphasizes balancing efficacy with tolerability, translating research into patient care, and exploring emerging therapies and trial results from major conferences. A notable strength is the breadth of senior clinician perspectives, practical insights from community practice, and a clear focu... more

Where can I find podcast stats for Lung Cancer Update?

Rephonic provides a wide range of podcast stats for Lung Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Lung Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Lung Cancer Update get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Lung Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Lung Cancer Update?

Rephonic provides comprehensive predictive audience data for Lung Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Lung Cancer Update have?

To see how many followers or subscribers Lung Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Lung Cancer Update?

These podcasts share a similar audience with Lung Cancer Update:

1. Gastrointestinal Cancer Update
2. Two Onc Docs
3. Prostate Cancer Update
4. Oncology Today with Dr Neil Love
5. Breast Cancer Update

How many episodes of Lung Cancer Update are there?

Lung Cancer Update launched 20 years ago and published 359 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Lung Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Lung Cancer Update?

Rephonic pulls ratings and reviews for Lung Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Lung Cancer Update?

Rephonic provides full transcripts for episodes of Lung Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Lung Cancer Update?

Recent guests on Lung Cancer Update include:

1. Solange Peters
2. Josh Sabari
3. Ticiana Leal
4. Charu Agarwal
5. Tisiana Leal
6. John Heymach
7. Maurice Pérol
8. Dr. Joshua Sabari

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days